<DOC>
	<DOCNO>NCT02649231</DOCNO>
	<brief_summary>96 recently detoxify alcoholic randomize receive either 3 session ketamine ( 0.8 mg/kg IV 45 minute ) placebo plus manualised psychological therapy , 3 session ketamine placebo plus simple psychoeducation . Patients assess 3 6 month range psychological biological variable . Primary endpoint % day abstinent 3 6 month relapse rate 6 month . Secondary endpoint include depressive symptom , crave , quality life .</brief_summary>
	<brief_title>Ketamine Reduction Alcoholic Relapse</brief_title>
	<detailed_description />
	<mesh_term>Alcohol Drinking</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Meet either ) DSM5 criterion severe alcohol use disorder b ) DSMIV criterion alcohol dependence within last 12 month ; Currently abstinent alcohol ( breathalyser BAC level 0.00 ) negative urine drug screening ( participant test positive THC history current cannabis dependency may include ) ; Minimum mild depression ( &gt; 14 Beck Depression InventoryII ) ; Capacity give inform consent define GCP guideline ; Willing able wear SCRAMX bracelet 6 month ; Females childbearing potential male must willing use effective method contraception ( hormonal barrier method birth control ; True abstinence ) time consent sign 6 week treatment discontinuation inform trial pregnancy occur . For purpose clarity , True abstinence line prefer usual lifestyle subject . Periodic abstinence ( e.g. , calendar , ovulation , symptothermal , postovulation method ) , declaration abstinence , withdrawal , spermicides lactational amenorrhoea method duration trial , acceptable method contraception ; Females childbearing potential must negative pregnancy test within 7 day prior registered trial treatment day first treatment . Currently take relapse prevention medication antidepressant ; Uncontrolled hypertension , systolic 140mm Hg great diastolic 90mm Hg great ; &lt; 16 &gt; 35 BMI History psychosis , firstdegree relative identify DSM5 DSMIV SCID ; comorbid current psychiatric diagnosis exclude depression , identify via selfreported identified medical professional ; Previous current diagnosis substance dependence / severe substance misuse disorder ; History neuropsychological difficulty One previous confirm seizure ; Currently take daily prescribe medication contraindicate SPC ketamine : 1 . Barbiturates and/or narcotic 2 . Atracurium tubocurarine 3 . Central nervous system ( CNS ) depressant ( e.g . phenothiazine , sedate H1 blocker skeletal muscle relaxant ) 4 . Anxiolytics , sedative hypnotics 5 . Thiopental , thyroid hormone 6 . Antihypertensive agent 7 . Theophylline methylxanthines . 8 . Halogenated anaesthetic 9 . OR psychotropic drug use screen assessment treatment week Liver function test &gt; 3 time normal level Where `` special warning precaution use '' accord SPC risk v benefit ratio favour give ketamine , assessment make physical examination medically qualified trial personnel , selfreport inspection medical note : 1 . Acute intermittent porphyria 2 . Dehydration hypovolemia 3 . Hyperthyroidism , patient receive thyroid replacement 4 . Pulmonary upper respiratory tract infection 5 . Severe Coronary artery disease , Cerebrovascular accident cerebral trauma 6 . Diabetes 7 . Known glaucoma globe injury 8 . Cirrhosis 9 . Epilepsy 10 . Neurological condition/brain damage 11 . Intracranial mass lesion , presence head injury hydrocephalus Suicidal ideation . Not willing use effective contraception ( female ) take pregnancy test ; Allergic reaction ketamine ; &gt; 10 previous detoxification alcohol ; Pregnant breastfeeding ; Allergies excipients IMP placebo ; Use another experimental investigational medicinal product likely interfere study medication within 3 month study enrolment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>